Hantz Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-150
Closed -$4K – 1060
2024
Q1
$4K Hold
150
– – ﹤0.01% 958
2023
Q4
$5K Buy
+150
New +$4.08K ﹤0.01% 904

Other funds holding ARKG

Hantz Financial Services's ARKG Position: Q2 2024 in Review

Hantz Financial Services sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 150 shares — an estimated $4K sold.

Hantz Financial Services first reported a position in ARKG in Q4 2023 and held it in 2 quarters. The position peaked at $5K in Q4 2023. 263 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • Hantz Financial Services reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • Hantz Financial Services sold 150 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $4K.
  • Hantz Financial Services first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 2 quarters.
  • Hantz Financial Services's ARK Genomic Revolution ETF position peaked at $5K in Q4 2023.
  • 263 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Hantz Financial Services's 13F filing for Q2 2024, filed 30 Jul 2024.